# High Ki67 Index and Bulky Disease Remain Significant Adverse Prognostic Factors in Patients with Diffuse Large B Cell Lymphoma before and after the Introduction of Rituximab

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/high-ki67-index-and-bulky-disease-remain-significant-adverse-prognostic-factors/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Francesco Gaudio,Annamaria Giordano,Tommasina Perrone,Domenico Pastore,Paola Curci,Mario Delia,Anna Napoli,Clara De Risi,Alessandro Spina,R Ricco,Vincenzo Liso,Giorgina Specchia |
| Citations | 65 |
| DOI | 10.1159/000324206 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2018368873 |
| PMID | 21430371 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Francesco Gaudio](https://scholariq.org/researchers/francesco-gaudio/)

## Paper primary topic

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)

## Paper topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Viral-associated cancers and disorders](https://scholariq.org/topics/viral-associated-cancers-and-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.